Schrodinger Inc (SDGR) News & EventsSDGRSchrodinger Inc

Stocks Surge as Oil Prices Retreat

Stocks were sharply higher on Thursday, erasing losses from the last two sessions as oil and fuel prices trimmed their recent surge. Saudi Arabia signaled progress in restoring capacity through its East-West pipeline, dampening part of the recent rise in wholesale energy inflation.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:The SECto facilitate trading of tokenized stocksGeneracannounced ato supply Amazonand its affiliates with up to a total of $8B worth of backup power generators for data centersA group of 10 banks is providing ato support Blackstoneand Alphabet'snew cloud venture Crux AI, Reuters and Bloomberg reportedExxon Mobilis nearing ain Venezuela's oil fields, WSJ reportsOpenAIfor tracking, investigating, and disclosing instances of AI model misalignment, along with six reports on "unexpected or concerning model behavior" observed in the last six months2. WALL STREET CALLS:MacquarieTrip.comto OutperformFluence Energyto Underperform at Baird and to Neutral at Goldman SachsCitizensJ.B. Huntto OutperformGuggenheimLyftto NeutralBernsteinPalo Alto Networks, Okta, and SentinelOneto Market Perform3. AROUND THE WEB:Xpengplans to offer its technology to foreign automakers beyond its partner Volkswagen, Reuters reportsGlassHouse Research disclosed that the firm is short Astrana HealthLucid GroupCEO Silvio Napoli told Bloomberg in an interview that the company's work with restructuring consultant AlixPartners has concluded.Nebiussaid in an emailed statement to Bloomberg that the company is raising on-demand prices, effective October 1Apollo Globalis discussing with SoftBankpotentially increasing the size of its loan to $9B from $5.4B, Bloomberg says4. MOVERS:Schrodingerhigher afterunder its Nasdaq listing ruleIonQ (IONQ) increases after detailing itsKopingains after Oppenheimerof the stock with an Outperform ratingCopartfalls after HSBCthe stock to HoldCoreWeavelower after announcing a5. EARNINGS/GUIDANCE:Intuitits guidance for Q1 and FY27 in conjunction with its investor day meetingYetiits outlook for FY26 and FY30 as part of its own investor dayBrinkerLennar, with EPS and revenue missing consensusAmer Sportsfor Q3INDEXES:Near midday, the Dow was up 314.25, or 0.61%, to 51,776.15, the Nasdaq was up 411.33, or 1.58%, to 26,389.75, and the S&P 500 was up 79.40, or 1.05%, to 7,631.21.

Schrodinger Grants 2,243 Restricted Stock Units to Three New Employees

Schrodinger reported that on September 13, the company granted restricted stock units with respect to 2,243 shares of the company's common stock to three newly hired employees. These grants were made pursuant to the company's 2021 Inducement Equity Incentive Plan, were approved by the compensation committee of the board of directors pursuant to a delegation by the company's board of directors, and were made as a material inducement to such employees' acceptance of employment with the company in accordance with Nasdaq Listing Rule 5635(c)(4) as a component of his or her employment compensation. The RSUs vest over four years, with 25 percent of such RSUs vesting when such employee completes 12 months of continuous service measured from the vesting commencement date, and the balance of the RSUs vesting in a series of successive equal yearly installments of 1/4 of the original number of RSUs upon each such employee's completion of each additional year of service over the three-year period following the first anniversary of the vesting commencement date. The inducement grants are subject to the terms and conditions of award agreements covering the grants and the company's 2021 Inducement Equity Incentive Plan.

Schrodinger Forms Tectora and Secures $55M Investment

Schrodinger announced the formation of Tectora, focused on developing innovative therapies for immunology and inflammation. Tectora concurrently closed a $55M Series A investment from NEA and RA Capital. In connection with the transaction, Schrodinger contributed two early-stage small molecule programs and, in exchange, received an equity stake in Tectora and is also eligible to receive future milestones and royalties. "Schrodinger has a track record of creating and enabling programs for licensing to pharma companies or joining forces with venture funds to build successful biotechnology companies such as Nimbus, Morphic, Structure and Ajax. These partnerships have collectively generated over $750 million in proceeds to Schrodinger," said Karen Akinsanya, Ph.D., President, Therapeutics R&D, and Chief Strategy Officer, Partnerships, at Schrodinger. "We co-founded Tectora with NEA and RA Capital to pair our breakthrough science with the dedicated capital and industry expertise needed to rapidly advance these programs to patients."